Ausgabe 2/2018
Inhalt (30 Artikel)
Older studies can underestimate prognosis of glioblastoma biomarker in meta-analyses: a meta-epidemiological study for study-level effect in the current literature
Victor M. Lu, Kevin Phan, Julia X. M. Yin, Kerrie L. McDonald
Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors
Anthony R. Guastella, Sharon K. Michelhaugh, Neil V. Klinger, Hassan A. Fadel, Sam Kiousis, Rouba Ali-Fehmi, William J. Kupsky, Csaba Juhász, Sandeep Mittal
Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma
Dai Kamamoto, Kentaro Ohara, Yohei Kitamura, Kazunari Yoshida, Yutaka Kawakami, Hikaru Sasaki
IDH1 mutation in human glioma induces chemical alterations that are amenable to optical Raman spectroscopy
Ortrud Uckermann, Wenmin Yao, Tareq A. Juratli, Roberta Galli, Elke Leipnitz, Matthias Meinhardt, Edmund Koch, Gabriele Schackert, Gerald Steiner, Matthias Kirsch
GOLPH3 promotes glioma progression via facilitating JAK2–STAT3 pathway activation
Shishuang Wu, Jiale Fu, Yu Dong, Qinghao Yi, Dong Lu, Weibing Wang, Yanhua Qi, Rutong Yu, Xiuping Zhou
PD-1/PD-L1 and immune-related gene expression pattern in pediatric malignant brain tumors: clinical correlation with survival data in Korean population
Kihwan Hwang, Eun Jung Koh, Eun Jin Choi, Tae Hee Kang, Jung Ho Han, Gheeyoung Choe, Sung-Hye Park, Jennifer Holmes Yearley, Lakshmanan Annamalai, Wendy Blumenschein, Manjiri Sathe, Terri McClanahan, Hun Jung, Kyu-Chang Wang, Seung-Ki Kim, Chae-Yong Kim
Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery
Adrienn Volak, Stanley G. LeRoy, Jeya Shree Natasan, David J. Park, Pike See Cheah, Andreas Maus, Zachary Fitzpatrick, Eloise Hudry, Kelsey Pinkham, Sheetal Gandhi, Bradley T. Hyman, Dakai Mu, Dwijit GuhaSarkar, Anat O. Stemmer-Rachamimov, Miguel Sena-Esteves, Christian E. Badr, Casey A. Maguire
Oligodendrogliomas in pediatric and teenage patients only rarely exhibit molecular markers and patients have excellent survivals
Yan-Xi Li, Abudumijiti Aibaidula, Zhifeng Shi, Hong Chen, Kay Ka-Wai Li, Nellie Yuk-Fei Chung, Ryan Rui Yang, Danny Tat-Ming Chan, Wai Sang Poon, Ka Lok Ryan Lee, Ying Mao, Jinsong Wu, Aden Ka-yin Chan, Liangfu Zhou, Ho-Keung Ng
Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model
Toshitaka Fujihara, Yoshifumi Mizobuchi, Kohei Nakajima, Teruyoshi Kageji, Kazuhito Matsuzaki, Keiko T. Kitazato, Ryotaro Otsuka, Keijiro Hara, Hideo Mure, Toshiyuki Okazaki, Kazuyuki Kuwayama, Shinji Nagahiro, Yasushi Takagi
Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis
Fu Zhao, Jing Zhang, Peng Li, Qiangyi Zhou, Shun Zhang, Chi Zhao, Bo Wang, Zhijun Yang, Chunde Li, Pinan Liu
Cranial nerve outcomes after primary stereotactic radiosurgery for symptomatic skull base meningiomas
Andrew Faramand, Hideyuki Kano, Ajay Niranjan, Stephen A. Johnson, Mohab Hassib, Kyung-Jae Park, Yoshio Arai, John C. Flickinger, L. Dade Lunsford
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma
Maarten M. J. Wijnenga, Pim J. French, Hendrikus J. Dubbink, Winand N. M. Dinjens, Peggy N. Atmodimedjo, Johan M. Kros, Ruth Fleischeuer, Clemens M. F. Dirven, Arnaud J. P. E. Vincent, Martin J. van den Bent
Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy
Pim B. van der Meer, Esther J. J. Habets, Ruud G. Wiggenraad, Antoinette Verbeek-de Kanter, Geert J. Lycklama à Nijeholt, Hanneke Zwinkels, Martin Klein, Linda Dirven, Martin J. B. Taphoorn
Pazopanib efficacy in recurrent central nervous system hemangiopericytomas
Caroline Apra, Agusti Alentorn, Karima Mokhtari, Michel Kalamarides, Marc Sanson
Contrast enhancement predicting survival in integrated molecular subtypes of diffuse glioma: an observational cohort study
Johann-Martin Hempel, Cornelia Brendle, Benjamin Bender, Georg Bier, Marco Skardelly, Irina Gepfner-Tuma, Franziska Eckert, Ulrike Ernemann, Jens Schittenhelm
Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?
Enrico Franceschi, Giuseppe Lamberti, Alexandro Paccapelo, Monica Di Battista, Giovenzio Genestreti, Santino Minichillo, Antonella Mura, Stefania Bartolini, Raffaele Agati, Alba A. Brandes
Management of glioblastoma at safety-net hospitals
Michael G. Brandel, Robert C. Rennert, Christian Lopez Ramos, David R. Santiago-Dieppa, Jeffrey A. Steinberg, Reith R. Sarkar, Arvin R. Wali, J. Scott Pannell, James D. Murphy, Alexander A. Khalessi
18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study
Chirag B. Patel, Elisa Fazzari, Ararat Chakhoyan, Jingwen Yao, Catalina Raymond, Huytram Nguyen, Jasmine Manoukian, Nhung Nguyen, Whitney Pope, Timothy F. Cloughesy, Phioanh L. Nghiemphu, Johannes Czernin, Albert Lai, Benjamin M. Ellingson
Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide
Erkan Topkan, Ugur Selek, Yurday Ozdemir, Berna A. Yildirim, Ozan C. Guler, Fuat Ciner, Huseyin Mertsoylu, Kadir Tufan
Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity
Kevin Diao, Shelly X. Bian, David M. Routman, Cheng Yu, Jason C. Ye, Naveed A. Wagle, Michael K. Wong, Gabriel Zada, Eric L. Chang
MR-spectroscopic imaging of glial tumors in the spotlight of the 2016 WHO classification
Elie Diamandis, Carl Phillip Simon Gabriel, Urs Würtemberger, Konstanze Guggenberger, Horst Urbach, Ori Staszewski, Silke Lassmann, Oliver Schnell, Jürgen Grauvogel, Irina Mader, Dieter Henrik Heiland
The influence of preoperative dependency on mortality, functional recovery and complications after microsurgical resection of intracranial tumors
Martin N. Stienen, David Y. Zhang, Morgan Broggi, Dominik Seggewiss, Stefano Villa, Silvia Schiavolin, Oliver Bozinov, Niklaus Krayenbühl, Johannes Sarnthein, Paolo Ferroli, Luca Regli
Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED10
Aryavarta M. S. Kumar, Jonathan Miller, Seth A. Hoffer, David B. Mansur, Michael Coffey, Simon S. Lo, Andrew E. Sloan, Mitchell Machtay
Prediction of survival in patients affected by glioblastoma: histogram analysis of perfusion MRI
Andrea Romano, Luca Pasquini, Alberto Di Napoli, Francesca Tavanti, Alessandro Boellis, Maria Camilla Rossi Espagnet, Giuseppe Minniti, Alessandro Bozzao
Initial brain metastasis velocity: does the rate at which cancers first seed the brain affect outcomes?
Michael H. Soike, Emory R. McTyre, Ryan T. Hughes, Michael Farris, Christina K. Cramer, Michael C. LeCompte, Claire M. Lanier, Jimmy Ruiz, Jing Su, Kounosuke Watabe, J. Daniel Bourland, Michael T. Munley, Stacey O’Neill, Adrian W. Laxton, Stephen B. Tatter, Michael D. Chan
Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design
Richard G. Everson, Yuuri Hashimoto, Jacob L. Freeman, Tiffany R. Hodges, Jason Huse, Shouhao Zhou, Joanne Xiu, David Spetzler, Nader Sanai, Lyndon Kim, Santosh Kesari, Andrew Brenner, Franco De Monte, Amy Heimberger, Shaan M. Raza
Treatment and survival of glioblastoma patients in Denmark: The Danish Neuro-Oncology Registry 2009–2014
Steinbjørn Hansen, Birthe Krogh Rasmussen, René Johannes Laursen, Michael Kosteljanetz, Henrik Schultz, Bente Mertz Nørgård, Rikke Guldberg, Kim Oren Gradel
Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma’s grade and IDH status
Céline De Looze, Alan Beausang, Jane Cryan, Teresa Loftus, Patrick G. Buckley, Michael Farrell, Seamus Looby, Richard Reilly, Francesca Brett, Hugh Kearney
Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?
Geert O. Janssens, Christof M. Kramm, Andre O. von Bueren
Leptomeningeal disease in uveal melanoma: a case series
Isabella C. Glitza, Sujan T. Reddy, Sapna P. Patel